Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | XBP1 | P17861 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.48 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.42 |
| ▸ | ACLY | P53396 | 2/20 | 0.41 |
| ▸ | ACACA | Q13085 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | MET | P08581 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | PLCG1 | P19174 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11996897 | 0.94 | KMT2A (0.54) | MEN1KMT2AKDM4EMAPTGAA | |
| Gamma Oryzanol SCHEMBL29354302 | 0.90 | MEN1 (0.60) | MEN1KMT2AKDM4EMAPTGAA | |
| SCHEMBL29524845 | 0.90 | MEN1 (0.63) | MEN1KMT2AKDM4EMAPTGAA | |
| Gamma Oryzanol SCHEMBL718726 | 0.90 | MEN1 (0.60) | MEN1KMT2AKDM4EMAPTGAA | |
| Gamma Oryzanol SCHEMBL29357024 | 0.90 | MEN1 (0.60) | MEN1KMT2AKDM4EMAPTGAA | |
| Gamma Oryzanol SCHEMBL23105398 | 0.90 | MEN1 (0.60) | MEN1KMT2AKDM4EMAPTGAA | |
| SCHEMBL12152371 | 0.90 | MEN1 (0.63) | MEN1KMT2AKDM4EMAPTGAA | |
| SCHEMBL11994839 | 0.90 | MEN1 (0.52) | MEN1KMT2AKDM4EMAPTGAA | |
| Gamma Oryzanol SCHEMBL21235210 | 0.90 | MEN1 (0.60) | MEN1KMT2AKDM4EMAPTGAA | |
| Gamma Oryzanol SCHEMBL12152368 | 0.90 | MEN1 (0.60) | MEN1KMT2AKDM4EMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8048335-B2 | Cholesteric liquid crystal composition | CHISSO CORPORATION (JP) | 2011-11-01 | — | — | US | disclosed |
| US-8048335-B2 | Cholesteric liquid crystal composition | CHISSO CORPORATION (JP) | 2011-11-01 | — | — | US | disclosed |
| US-8048336-B2 | Polymerizable cholesteric liquid crystal composition and its use | CHISSO CORPORATION (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20100272924-A1 | POLYMERIZABLE CHOLESTERIC LIQUID CRYSTAL COMPOSITION AND ITS USE | CHISSO CORPORATION (JP) | 2010-10-28 | — | — | US | disclosed |
| US-20100086506-A1 | CHOLESTERIC LIQUID CRYSTAL COMPOSITION | CHISSO CORPORATION (JP) | 2010-04-08 | — | — | US | disclosed |
| US-20100086506-A1 | CHOLESTERIC LIQUID CRYSTAL COMPOSITION | CHISSO CORPORATION (JP) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100086506-A1 | CHOLESTERIC LIQUID CRYSTAL COMPOSITION | CYP46A1, NR1H3, NR1H4 | MEN1 970/4885KMT2A 3595/4885KDM4E 4220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.